AnalystsEliana Merle
Eliana Merle's Stock Forecasts

Analyst Ranking
Top 15%
#790 out of 5230 analysts
Average Return
+8.9%
Win Rate
46%45 out of 98
Risk vs Reward
Poor
Good

Eliana Merle's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Iveric Bio IncISEE
+237.97%$11.01$37.21
2022-08-02 -
2023-05-03
Strong Buy
Cymabay Therapeutics IncCBAY
+213.84%$1.59$4.99
2020-03-13 -
2021-03-12
Strong Buy
Cymabay Therapeutics IncCBAY
+166.61%$12.07$32.18
2023-08-14 -
2024-02-14
Strong Buy
Kymera Therapeutics IncKYMR
+151.00%$31.14$78.16
2025-05-13 -
2026-03-27
Strong Buy
Kadmon Holdings IncKDMN
+148.04%$3.83$9.50
2021-05-21 -
2021-11-09
Strong Buy

Eliana Merle Analyst Color

Get additional color on Eliana Merle's coverage of popular stocks

Eliana Merle's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Ionis Pharmaceuticals IncIONS
1Strong Buy$106.00+46.92%Maintains
4 days ago
Uniqure NvQURE
6Hold$25.00+69.26%Maintains
7 days ago
Regeneron Pharmaceuticals IncREGN
1Strong Buy$923.00+25.12%Initiates Coverage On
24 days ago
Biomarin Pharmaceutical IncBMRN
4Strong Buy$105.00+93.94%Maintains
a month ago
Tpg IncTPG
2Strong Buy$56.00+43.22%Maintains
a month ago
Gossamer Bio IncGOSS
5Strong Sell$0.30-13.54%Downgrades
a month ago
Vertex Pharmaceuticals IncVRTX
2Strong Buy$607.00+40.16%Maintains
a month ago
Kymera Therapeutics IncKYMR
4Strong Buy$133.00+70.16%Maintains
2 months ago
Tyra Biosciences IncTYRA
2Strong Buy$59.00+62.58%Initiates Coverage On
2 months ago
Sagimet Biosciences IncSGMT
2Hold$8.00+63.60%Initiates Coverage On
2 months ago
Ptc Therapeutics IncPTCT
1Strong Buy$119.00+79.95%Upgrades
2 months ago
Mbx Biosciences IncMBX
1Strong Buy$66.00+131.58%Initiates Coverage On
2 months ago
Madrigal Pharmaceuticals IncMDGL
6Strong Buy$964.00+88.77%Initiates Coverage On
2 months ago
Inventiva SaIVA
2Strong Buy$18.00+214.69%Initiates Coverage On
2 months ago
Insmed IncINSM
1Strong Buy$231.00+58.98%Initiates Coverage On
2 months ago
Ascendis Pharma AASND
3Strong Buy$342.00+57.64%Initiates Coverage On
2 months ago
4d Molecular Therapeutics IncFDMT
1Strong Buy$33.00+253.70%Initiates Coverage On
2 months ago
Bridgebio Pharma IncBBIO
5Strong Buy$80.00+14.78%Initiates Coverage On
2 months ago
Apellis Pharmaceuticals IncAPLS
8Hold$24.00+41.43%Initiates Coverage On
2 months ago
Alnylam Pharmaceuticals IncALNY
4Strong Buy$527.00+66.06%Initiates Coverage On
2 months ago
Moderna IncMRNA
9Hold$34.00-31.40%Assumes
3 months ago
Altimmune IncALT
2Strong Buy$24.00+694.70%Maintains
8 months ago
Rapt Therapeutics IncRAPT
4Hold$9.00-84.49%Maintains
8 months ago
Anaptysbio IncANAB
5Hold$20.00-65.16%Maintains
8 months ago
Sarepta Therapeutics IncSRPT
1Hold$12.00-39.91%Downgrades
8 months ago
Prokidney CorpPROK
1Strong Buy$8.00+400.00%Maintains
9 months ago
Curevac NvCVAC
3Hold$5.50+18.03%Downgrades
9 months ago
Arvinas IncARVN
5Strong Buy$21.00+107.92%Maintains
a year ago
89bio IncETNB
3Strong Buy$38.00N/AMaintains
a year ago
Akero Therapeutics IncAKRO
4Strong Buy$109.00N/AMaintains
a year ago
Zentalis Pharmaceuticals IncZNTL
4Hold$2.20N/AMaintains
a year ago
Revolution Medicines IncRVMD
2Strong Buy$71.00N/AMaintains
a year ago
Biontech SeBNTX
4Hold$131.00N/AMaintains
2 years ago
Kodiak Sciences IncKOD
3Hold$5.00N/AMaintains
2 years ago
Terns Pharmaceuticals IncTERN
2Strong Buy$18.00N/AMaintains
2 years ago
Cymabay Therapeutics IncCBAY
5Hold$32.50N/ADowngrades
2 years ago
Iveric Bio IncISEE
2Hold$40.00N/ADowngrades
3 years ago
Monte Rosa Therapeutics IncGLUE
1Strong Buy$22.00N/AInitiates Coverage On
3 years ago
Regenxbio IncRGNX
1Strong Buy$47.00N/AMaintains
4 years ago
Kadmon Holdings IncKDMN
1Strong Buy$9.00N/AInitiates Coverage On
5 years ago
Amicus Therapeutics IncFOLD
2Strong Buy$16.00N/AInitiates Coverage On
5 years ago
Galapagos NvGLPG
2Hold$134.00N/AMaintains
6 years ago
Alexion Pharmaceuticals IncALXN
1Hold$121.00N/AInitiates Coverage On
6 years ago
Cartesian Therapeutics IncRNAC
1Strong Buy$10.00N/AInitiates Coverage On
6 years ago
Tesaro IncTSRO
1Strong Buy$68.00N/AMaintains
7 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.